Key Resolutions and Details

1. Increase in Authorized Share Capital

  • Current Capital: ₹70,00,00,000 divided into 7,00,00,000 equity shares of ₹10 each
  • Proposed Capital: ₹100,00,00,000 divided into 10,00,00,000 equity shares of ₹10 each
  • Increase: Creation of additional 3,00,00,000 equity shares of ₹10 each
  • Purpose: To meet future capital structure requirements and enable issuance of further shares
  • Requirement: Approval under Sections 13, 61, 64 of Companies Act, 2013
  • Consequence: Clause V of Memorandum of Association to be altered accordingly

2. Material Related Party Transactions with SMCV Management Services Private Limited

  • Related Party: SMCV Management Services Private Limited (body corporate where UGPatwardhan Services Private Limited, promoter of GTT, holds more than 20% equity)
  • Transaction Types: Availing/rendering services, lending/borrowings with interest, buying/selling/leasing property, reimbursement of expenses, transfer of resources/services/obligations
  • Maximum Amount: ₹20 crores during FY 2026-27
  • Previous Transactions: FY 2025-26 - Inter-company deposit (loan taken): ₹8,90,00,000; Interest payable: ₹21,945; Total: ₹8,90,21,945
  • Related Party Financials (FY 2025-26): Turnover: Nil; Profit After Tax: (₹7,50,549.74); Net Worth: ₹1,42,49,450.26
  • Voting Restrictions: Related parties shall abstain from voting as per SEBI Listing Regulations and Section 188 of Companies Act, 2013

3. Regularization of Mr. Sai Manik Sud as Independent Director

  • DIN: 11741274
  • Initial Appointment: May 26, 2026 as Additional Director
  • Proposed Term: 5 consecutive years from May 26, 2026 to May 25, 2031
  • Qualifications: Graduate of National Law University, Delhi and University of Leeds; LPC qualification
  • Experience: Cross-border legal environments, commercial disputes, Supreme Court researcher
  • Shareholding: Nil
  • Remuneration: Not disclosed

4. Regularization of Dr. Charudatta Palwe as Independent Director

  • DIN: 00532670
  • Initial Appointment: June 9, 2026 as Additional Director
  • Proposed Term: 5 consecutive years from June 9, 2026 to June 8, 2031
  • Qualifications: Medical doctor and biomedical engineer
  • Experience: Healthcare administration, business development, strategic planning
  • Other Directorships: Aryaman Spaces Limited, Supra Out of Home Publicity Private Limited, Vendekin Technologies Private Limited, Cannaturals Private Limited, C7 Leaf Private Limited
  • Shareholding: Nil
  • Remuneration: Not disclosed

5. Conversion of Promoter Loans/ICDs into Equity Shares

  • Lenders: SMCV Management Services Private Limited and other promoters
  • Purpose: To strengthen capital base, improve debt-equity mix, reduce leverage, support long-term growth
  • Conversion Terms: To be determined by Board in accordance with Companies Act, 2013, SEBI ICDR Regulations, and other applicable laws
  • Approval Requirement: Special resolution under Section 62(3) of Companies Act, 2013
  • Shares Ranking: Pari passu with existing equity shares

Voting Process Details

  • E-voting Period: July 04, 2026 (9:00 AM IST) to August 02, 2026 (5:00 PM IST)
  • Cut-off Date: June 26, 2026 for determining eligible shareholders
  • E-voting Provider: Central Depository Services (India) Limited (CDSL)
  • Scrutinizer: M/s. Kirti Sharma & Associates, Practicing Company Secretary
  • Results Announcement: On or before August 04, 2026 on company website and BSE
  • Deemed Passing Date: August 02, 2026 (last date of e-voting)

Financial Impact

  • Increase in authorized share capital will enable future equity issuances
  • RPTs up to ₹20 crores may impact FY 2026-27 financials
  • Loan conversion will reduce liabilities and improve net worth
  • Director appointments involve remuneration terms to be determined